# EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions

> **NCT04893577** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 10 (actual)

## Conditions studied

- Herpes Simplex Oral

## Interventions

- **DRUG:** EDTA
- **DRUG:** Abreva

## Key facts

- **NCT ID:** NCT04893577
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-20
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-08-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893577, "EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04893577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*